Update on linear endobronchial ultrasound

Area of Science:

• Pulmonology
• Oncology
• Diagnostic Imaging

Background:

• Linear endobronchial ultrasound (EBUS) is vital for lung cancer diagnosis and mediastinal staging.
• Recent updates in the International Association for the Study of Lung Cancer (IASLC) TNM staging and neoadjuvant therapy guidelines impact EBUS utility.

Purpose of the Study:

• To review key developments in EBUS for lung cancer management.
• To examine the evolving role of EBUS-guided tissue acquisition and rapid on-site evaluation (ROSE).

Main Methods:

• Review of updated IASLC TNM staging (9th edition).
• Analysis of emerging EBUS-guided biopsy techniques (intranodal forceps biopsy, cryobiopsy).
• Evaluation of artificial intelligence integration in ROSE.

Main Results:

• The IASLC 9th edition enhances nodal classification, stressing accurate EBUS lymph node assessment.
• New biopsy methods yield larger samples, improving diagnosis for lung cancer, lymphoma, and benign diseases.
• AI in ROSE improves real-time diagnostics and overcomes traditional limitations.

Conclusions:

• EBUS is now central to personalized lung cancer care.
• Understanding updated staging, therapy guidelines, and biopsy strategies is essential.
• Future research should focus on evidence-based algorithms integrating these innovations for optimal patient outcomes.